Arterra Bioscience S.p.A. (BIT:ARBS)

Market Cap	18.51M +23.0%
Revenue (ttm)	4.70M +34.8%
Net Income	2.01M +65.7%
EPS	0.30
Shares Out	6.66M
PE Ratio	9.23
Forward PE	n/a
Dividend	0.13 (4.68%)
Ex-Dividend Date	May 4, 2026

Volume	5,250
Open	2.730
Previous Close	2.780
Day's Range	2.730 - 2.780
52-Week Range	2.240 - 3.580
Beta	0.67
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 26, 2026

About Arterra Bioscience

Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. The company develops technological platforms, extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceutics sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Napoli, Italy.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 34
• Stock Exchange: Borsa Italiana
• Ticker Symbol: ARBS

Financial Performance

In 2025, Arterra Bioscience's revenue was 4.70 million, an increase of 12.74% compared to the previous year's 4.17 million. Earnings were 2.01 million, an increase of 50.09%.